Archive for June, 2006

Two Experts Take on Biotech: TheStockAdvisors.com Features John McCamant and Michael Shulman

By PR Web - Last updated: Monday, June 26, 2006

TheStockAdvisors.com (http://www.thestockadvisors.com), an interactive guide to financial newsletters announced today that it has provided readers with comments from two leading stock advisory groups. John McCamant and Michael Shulman comment on their outlook for two biotech companies BioCryst (BCRX: NASDAQ) and Genetech (DNA: NYSE). (PRWEB Jun 26, 2006)

Trackback URI: http://www.prweb.com/zingpr.php/U3F1YS1Ib3JyLUxvdmUtQ291cC1JbnNlLVplcm8=

US To Be Home For World?s First Shared Genetics Resource for Tourette Syndrome Research

By PR Web - Last updated: Saturday, June 24, 2006

The Tourette Syndrome Association of New Jersey (TSANJ) is announcing the creation of a first-ever DNA genetics study to help researchers worldwide discover causes, cures and treatment for Tourette Syndrome. It’s not only exciting from a medical perspective, but a that this program is originating here in the US. (Details below.) (PRWEB Jun 24, 2006)

When Robots Learn Social Skills

By PR Web - Last updated: Friday, June 23, 2006

Learning to communicate and adapting our behaviour to the information we receive has been fundamental to human evolution. If machines could do the same the intelligent talking robots of science fiction could become the stuff of science reality, as researchers aim to prove. (PRWEB Jun 23, 2006)

New Forum Allows the Public Worldwide to Publish Permanent Obituaries and Epitaphs

By PR Web - Last updated: Tuesday, June 20, 2006

Permanent epitaphs and obituaries can now be posted to www.World-Epitaph.com to honor family and aid genealogical and family history researchers. (PRWEB Jun 20, 2006)

Trackback URI: http://www.prweb.com/zingpr.php/SG9yci1GYWx1LUZhbHUtU2luZy1JbnNlLVplcm8=

Group Self-Organizing to Advocate for Cures to NF2

By PR Web - Last updated: Friday, June 16, 2006

Advocure is lobbying government and putting a more prominent face on this rare, but devastating, genetic disease. (PRWEB Jun 16, 2006)

Trackback URI: http://www.prweb.com/dingpr.php/UGlnZy1FbXB0LVNxdWEtU2luZy1JbnNlLVplcm8=

miRNA Tools from Gene Tools Gene Tools, LLC Announces Multi-blocking Morpholinos for microRNA Knockdowns

By PR Web - Last updated: Sunday, June 11, 2006

Gene Tools announces new products for microRNA knockdowns: Multi-blocking Morpholino oligos. (PRWEB Jun 8, 2006)

Major Discovery: How Carcinogens Cause Cancer

By PR Web - Last updated: Sunday, June 11, 2006

The current belief in medical research holds that most cancers are caused by exposure to carcinogens, and that carcinogens cause cancer by damaging DNA. However, the huge effort and billions of dollars invested by the NIH, private foundations, and pharmaceutical companies in searching for damaged DNA in cancer has produced few discoveries and little benefits to the public. The reason for this limited success is very simple. The cause of most cancers is not damaged DNA. (PRWEB May 27, 2006)

Trackback URI: http://www.prweb.com/dingpr.php/U3VtbS1FbXB0LUluc2UtUHJvZi1IYWxmLVplcm8=

CyGene Laboratories Fuels Genetic Knowledge Sharing Initiative with Biber Technologies Laboratory Information Management System (LIMS)

By PR Web - Last updated: Sunday, June 11, 2006

A leading in providing personalized genetic testing services to the consumer market, CyGene launches their latest genetic information knowledge portal at www.cygenedirect.com. (PRWEB Jun 9, 2006)

CyGene Laboratories Fuels Genetic Knowledge Sharing Initiative with Biber Technologies Laboratory Information Management System (LIMS)

By PR Web - Last updated: Friday, June 9, 2006

A leading in providing personalized genetic testing services to the consumer market, CyGene launches their latest genetic information knowledge portal at www.cygenedirect.com. (PRWEB Jun 9, 2006)

miRNA Tools from Gene Tools Gene Tools, LLC Announces Multi-blocking Morpholinos for microRNA Knockdowns

By PR Web - Last updated: Thursday, June 8, 2006

Gene Tools announces new products for microRNA knockdowns: Multi-blocking Morpholino oligos. (PRWEB Jun 8, 2006)